Pritchard v. Blue Cross Blue Shield of Illinois

District Court, W.D. Washington·Decided May 4, 2021·No. 3:20-cv-06145·Unknown

Opinion

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF WASHINGTON AT TACOMA C.P., by and through his parents, Patricia CASE NO. 3:20-cv-06145-RJB Pritchard and Nolle Pritchard; and PATRICIA PRITCHARD, ORDER DENYING DEFENDANT’S Plaintiffs, v. ILLINOIS, Defendant.

This matter comes before the Court on Defendant Blue Cross Blue Shield of Illinois’ Motion to Dismiss (Dkt. 17). The Court has considered the pleadings filed in support of and in opposition to the motion and the file herein. Both parties request oral argument, but the Court finds that it is not necessary to fairly decide the motion. The fundamental issue in this motion is whether a plaintiff who alleges that he was denied insurance coverage for medical treatment because he is transgender states a claim for sex discrimination under Section 1557 of the Affordable Care Act (“ACA”). The Court finds that he does. 1. Background Plaintiffs are C.P., a fifteen-year-old boy, and his mother, Patricia Pritchard. Dkt. 1. C.P. is a transgender male, which means that he has a male gender identity even though the sex

assigned to him at birth was female. Id. C.P. has been living as a male since 2015, and his birth certificate, legal name, social security information, and passport all reflect his male identity. Id. Patricia Pritchard receives health care coverage through her work under the Catholic Health Initiatives Medical Plan (“the Plan”), and C.P. is enrolled in that plan as her dependent. Id. The Plan sponsor is Catholic Health Initiatives. Id. Defendant, Blue Cross Blue Shield of Illinois (“BCBS”), is the claims administrator. Id. C.P. has gender dysphoria. Id. Gender dysphoria is a feeling of clinically significant stress and discomfort that can result from being transgender, or, more specifically, from having an incongruence between one’s gender identity and the sex assigned to that person at birth. Id. at

5. The American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (“DSM-5”) recognizes gender dysphoria as a medical condition that can be extremely serious, resulting in anxiety, depression, or even death. Dkt. 1 at 6. 2. The Insurance Plan: The fundamental dispute in this matter is over an exclusion in the Plan (“the Exclusion”), which states: Transgender Reassignment Surgery Not Covered: Benefits shall not be provided for treatment, drugs, medicines, therapy, counseling services and supplies for, or leading to, gender reassignment surgery. Dkt. 1-1 at 61. Two provisions of BCBS’s Medical Policies are also relevant.1 First, a provision that defines when gender reassignment surgery is “Medically Necessary”: Gender reassignment surgery – also known as transsexual surgery or sex reassignment surgery – and related services may be considered medically necessary when meeting the criteria for gender dysphoria listed below. Otherwise, gender reassignment surgery and related services will be considered not medically necessary. Criteria for Coverage of Gender Reassignment Surgery and Related Services: The individual being considered for surgery and related services must meet ALL the following criteria. The individual must have:  Reached the age if majority; AND  The capacity to make a fully informed decision and to consent for treatment; AND (ALERT – For Gender Reassignment Surgery and Related Services for Children and Adolescents within this coverage, proceed down through this coverage section to the area following NOTE 4.) …

Dkt. 1-7 at 2–3 (“Age Exclusion”). Second, “NOTE 4,” which reads: Gender Reassignment Surgery and Related Services for Children and Adolescents: The following services may be considered medically necessary for the treatment of gender dysphoria for children and adolescents:  Hormone therapy (such as, puberty-suppressing hormones or masculinizing/feminizing hormones);  Psychological services, including but not limited to psychotherapy, social therapy, and family counseling; and/or  Chest surgery for FtM individuals. Id. at 6. Plaintiffs were denied coverage for treatment of C.P.’s gender dysphoria. Dkt. 1. In 2016, C.P.’s doctor determined C.P. needed a Vantas implant. Dkt. 1 at 9. A Vantas implant is a surgically implanted device that delivers hormones to delay the onset of puberty. Id. BCBS initially approved coverage for this Vantas implant, but later claimed the coverage approval was in error and subsequently covered only part of the implant and related treatment. Id. at 10. 1 It is not clear whether the Medical Policies are binding terms of the Plan, but the Court will assume for purposes of this motion that they are. In 2019, C.P.’s doctors concluded that a second Vantas implant, a mastectomy, and chest reconstruction surgery were medically necessary to treat his gender dysphoria. Id. at 11. BCBS denied coverage for these procedures and related treatment. Id. BCBS has since covered the cost of some medications related to C.P.’s second Vantas implant, but not medications or treatment related to his chest surgery. Id. at 12.

Free access — add to your briefcase to read the full text and ask questions with AI

Pritchard v. Blue Cross Blue Shield of Illinois, (W.D. Wash. 2021).

Pritchard v. Blue Cross Blue Shield of Illinois (Pritchard v. Blue Cross Blue Shield of Illinois) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

City of Los Angeles v. Lyons
461 U.S. 95 (Supreme Court, 1983)
Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Bostock v. Clayton County
590 U.S. 644 (Supreme Court, 2020)
Andrea Schmitt v. Kaiser Foundation Health Plan
965 F.3d 945 (Ninth Circuit, 2020)
David Schwake v. Arizona Board of Regents
967 F.3d 940 (Ninth Circuit, 2020)
Franciscan Alliance, Inc. v. Burwell
227 F. Supp. 3d 660 (N.D. Texas, 2016)
Prescott v. Rady Children's Hospital-San Diego
265 F. Supp. 3d 1090 (S.D. California, 2017)
And v. Essentia Health
342 F. Supp. 3d 947 (D. Maine, 2018)